The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s tissue-specific delivery vehicle to transport gene editing cargo to the lung cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback